Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Reliance Global Group Inc's Business Segments
Reliance Global Group Inc's reported revenue by business segment and by geographic
region, quarterly and annual, normalized against the consolidated income statement.
Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber
access adds the full segment history and operating income by segment.
Reportable Segments
-
Per the company's own filing, this quarter
Total Revenue
$ 4
Consolidated, this quarter
Regions Reported
-
Geographic regions, this quarter
Reliance Global Group, Inc. is a holding company that acquires, owns, and manages insurance and technology-focused businesses. The company primarily acquires and operates wholesale and retail insurance agencies and develops proprietary InsurTech platforms to improve distribution efficiency, scalability, and operational integration. Reliance targets fragmented markets by centralizing operational infrastructure, leveraging proprietary technology, and generating recurring cash flows for long-term value creation.
As of December 31, 2025, Reliance owned six insurance-related businesses and various proprietary technology platforms. In 2025, the company realigned its portfolio by selling certain insurance brokerage assets and repaying long-term debt. It also adopted a digital asset treasury strategy to allocate treasury assets to cryptocurrencies and blockchain initiatives, overseen by a Crypto Advisory Board.
In 2026, Reliance launched EZRA International Group to expand through majority investments in technology-focused businesses, introducing the Scale51 model to acquire controlling interests, generally around 51%, in technology-driven companies. The company continues to operate its insurance brokerage and InsurTech platforms while pursuing investments in artificial intelligence, cybersecurity, fintech, insurtech, medtech, and digital health sectors.
Recent transactions include a secured convertible note and share purchase agreement with Enquantum Ltd., a cybersecurity company, and a non-binding term sheet to acquire a majority interest in Scent Medical Technologies Ltd., an Israeli diagnostics company developing AI-based breath diagnostic technologies.